Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price rose 9% on Wednesday . The stock traded as high as $162.76 and last traded at $162.76. Approximately 3 shares were traded during trading, a decline of 100% from the average session volume of 663 shares. The stock had previously closed at $149.2780.
Merck KGaA Stock Up 4.5%
The firm has a market capitalization of $21.04 billion, a P/E ratio of 24.85 and a beta of 0.96. The firm’s 50 day moving average is $145.48 and its two-hundred day moving average is $143.43. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
- EVs Are Big Winners of the Iran War—Just Not American Ones
- Dividend Increases: From Over 10% Yields to Over 10% Dividend Growth
- From Quantum to Clothing: Insider Trades Hit 3 Big Names
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
